|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 60.74 USD | +1.47% |
|
-2.02% | +12.61% |
| 02-11 | Tranche Update on Bristol-Myers Squibb Company's Equity Buyback Plan announced on October 27, 2016. | CI |
| 02-09 | AstraZeneca's Evinova Enters Clinical Development AI Partnership Deal | MT |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- BMY Stock
- Consensus Bristol-Myers Squibb Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition